Finance

Beta
Ask
Lists
PI6:FRA
Palvella Therapeutics Inc
€103.00
+5.10%
(+5.00) 1D
Jun 23, 8:08:00 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PI6...
Open
€103.00
High
€103.00
Low
€103.00
Mkt. cap
1.72B
Avg. vol.
8.00
Volume
0.00
52-wk high
€124.00
52-wk low
€17.20
No. of employees
29
Open
€103.00
High
€103.00
Low
€103.00
Mkt. cap
1.72B
Avg. vol.
8.00
Volume
0.00
52-wk high
€124.00
52-wk low
€17.20
No. of employees
29
News stories
From sources across the web
About Palvella Therapeutics Inc
CEO-
Employees29
Founded-
Headquarters-
SectorBiotechnology
Websitepalvellatx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.12M
6.53M
7.12M
9.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.13M
3.65M
4.18M
5.52M
Operating expense
9.25M
10.18M
11.30M
14.86M
Total operating expenses
9.25M
10.18M
11.30M
14.86M
Operating income
-9.25M
-10.18M
-11.30M
-14.86M
Other non operating income
443.00K
-286.00K
-191.00K
54.00K
EBT including unusual items
-9.47M
-11.34M
-12.71M
-15.77M
EBT excluding unusual items
-9.47M
-11.34M
-12.71M
-15.77M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.47M
-11.34M
-12.71M
-15.77M
Net profit margin
-
-
-
-
Earnings per share
-0.86
-1.03
-1.08
-1.20
Interest and investment income
690.00K
628.00K
520.00K
1.07M
Interest expense
-1.35M
-1.51M
-1.74M
-2.04M
Net interest expenses
-664.00K
-882.00K
-1.22M
-966.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer